Form 8-K - Current report:
SEC Accession No. 0001641172-25-014234
Filing Date
2025-06-09
Accepted
2025-06-09 07:05:37
Documents
16
Period of Report
2025-06-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 46864
2 EX-99 ex99.htm EX-99 37493
3 GRAPHIC ex99_001.jpg GRAPHIC 14958
4 GRAPHIC ex99_002.jpg GRAPHIC 38215
  Complete submission text file 0001641172-25-014234.txt   380048

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE hrow-20250609.xsd EX-101.SCH 3943
6 XBRL DEFINITION FILE hrow-20250609_def.xml EX-101.DEF 26961
7 XBRL LABEL FILE hrow-20250609_lab.xml EX-101.LAB 37182
8 XBRL PRESENTATION FILE hrow-20250609_pre.xml EX-101.PRE 25581
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6655
Mailing Address 1A BURTON HILLS BLVD SUITE 200 NASHVILLE TN
Business Address 1A BURTON HILLS BLVD SUITE 200 NASHVILLE TN 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 251032809
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)